Company / Total Debt
Centessa Pharmaceuticals plc Total Debt History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$110.1M
FY2025
5-year range
$0 / $110.1M
FY2021-FY2025
Trend
+1.1%
vs FY2024
Sector context
#55 of 83
Health Care
What the data says
At $110M, Centessa Pharmaceuticals plc's total debt ranks #29 of 83 in the Health Care sector. Increased from $0 to $110M over the past 2 years.
Based on SEC 10-K filings.
$110M in FY2025 with a 3-year CAGR of +16.4%.
Increased from $0 to $110M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +16.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#29 of 83 in Health CareTop 34% of 83This company $110.1M Sector average $6.2B
▼
-98.2% below sector average
Key checks
Key Insights
- 3-year CAGR of +16.4%, indicating consistent growth.
- In FY2025, total debt increased 1.1% year-over-year.
- Ranks #55 out of 83 companies in the Health Care sector.
- Lowest total debt in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $110.1M | +1.1% |
| FY2024 | $108.9M | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $69.8M | -7.8% |
| FY2021 | $75.7M | - |
| FY2020 | $0 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026